Akers Biosciences Inc (AKR.L)

AKR.L on London Stock Exchange

277.50GBp
22 May 2015
Change (% chg)

-- (--)
Prev Close
277.50p
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,985
52-wk High
330.00p
52-wk Low
195.00p

AKR.L

Chart for AKR.L

About

Akers Biosciences, Inc. (ABI) is a United States-based company. The Company is a designer and manufacturer of rapid diagnostic screening and testing products. The Company’s products include BreathScan, BreathScan PRO, CHUBE, METRON, PIFA Heparin/PF4, PIFA PLUSS PF4, Tri-Cholesterol and VIVO. The Company’s objective is to apply... (more)
No analyst recommendations are available for AKR.L.

Overall

Beta: 1.05
Market Cap(Mil.): £13.75
Shares Outstanding(Mil.): 5.14
Dividend: --
Yield (%): --

Financials

  AKR.L Industry Sector
P/E (TTM): -- 309.95 39.17
EPS (TTM): -0.50 -- --
ROI: -24.82 -5.54 15.58
ROE: -25.10 -6.56 16.57
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: ValuEngine, Inc.
$49.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks